NCT02859402
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Dong-A University Busan, South Korea
- Keimyung University Dongsan Medical Center Daegu, South Korea
Clinical trial condition
Lymphoma, Extranodal NK-T-Cell
Explore clinical trials studying Lymphoma, Extranodal NK-T-Cell. Study availability and eligibility vary by location and protocol.
5 public trials
1 recruiting study
Lymphoma, Extranodal NK-T-Cell trial results
Not Yet Recruiting
Selinexor, Anti-PD-1 Antibody Plus Golidocitinib in R/R NKTCL
NCT06573138
- Conditions
- Lymphoma, Lymphoma, Extranodal NK-T-Cell, Lymphoma, Non-Hodgkin, +3 more
- Locations
-
Not specified
NCT03049449
- Conditions
- Enteropathy-Associated T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT00069238
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
Active, Not Recruiting
Pembrolizumab and Radiotherapy for Patients With NK/T Cell Lymphoma
NCT04417166
- Conditions
- Lymphoma, Lymphoma, Extranodal NK-T-Cell, Lymphoma, Non-Hodgkin, +3 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, China
- Shanghai Rui-Jin Hospital Shanghai, China